UNCONVENTIONAL PATTERN OF RESPONSE IN A METASTATIC MELANOMA PATIENT TREATED WITH IPILIMUMAB 0 By Francesco Spagnolo et al. on May 14, 2012 Embj We present the case of a 74 year old man who achieved a complete response for hepatic and cutaneous metastasis and stabilization of his lymph node metastases after treatment with ipilimumab at 10 mg/Kg.The patient was diagnosed with right foot cutaneous melanoma in February 2004.In October the patient became metastatic and he underwent three different lines of tradi-tional chemotherapy (Fotemustine, Dacarbazin and Carboplatin with Thalidomide) but each time a progression of the disease was noted. Consequently, the patient was enrolled in Protocol CA180008 and treated with ipilimumab 10mg/Kg every 3 weeks for 4 cycles.Ipilimumab has been established as a drug able to induce long-lasting responses, and has been approved for patients with metastatic melanoma in first- and second-line treatment by the FDA and in second-line treatment by the EMA. Case Report Share. Twitter Facebook Google+ Pinterest LinkedIn Tumblr Email
August 28, 2024 0 CHRONICLE OF AN ANNOUNCED SUICIDE. FORENSIC MEDICAL, PSYCHOLOGICAL AND PSYCHIATRIC CONSIDERATIONS
August 28, 2024 0 UNDERSTANDING THE COVID-19 PANDEMIC IN CALABRIA: LESSONS LEARNED AND INSIGHTS FROM RETROSPECTIVE DATA
August 28, 2024 0 INVESTIGATING KABUKI SYNDROME: CLINICAL AND GENETIC PROFILES REVEALED IN A CASE SERIES STUDY
